Temodar Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed o6-methylguanine-DNA-methyltransferase (MGMT) Negative Glioblastoma Multiforme (GBM)
Condition:   Glioblastoma Multiforme of Brain Interventions:   Biological: TVI-Brain-1;   Procedure: Standard of Care;   Radiation: Radiotherapy;   Drug: Temozolomide Sponsors:   TVAX Biomedical;   FDA Office of Orphan Products Development Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 13, 2023 Category: Research Source Type: clinical trials

Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed o6-methylguanine-DNA-methyltransferase (MGMT) Negative Glioblastoma Multiforme (GBM)
Condition:   Glioblastoma Multiforme of Brain Interventions:   Biological: TVI-Brain-1;   Procedure: Standard of Care;   Radiation: Radiotherapy;   Drug: Temozolomide Sponsor:   TVAX Biomedical Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 13, 2023 Category: Research Source Type: clinical trials